ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 4246 - 4260 of 5738 products
China Centralizes Hospital Drug Procurement
$5.00
Available
MicuRx Pairs US Phase II Trial of Novel Antibiotic with China Test
$5.00
Available
Eddingpharm Gains China Rights To Omega-3 Product in $169 Million Deal
$5.00
Available
Eisai to Build New Oral Solid Dose Plant in Suzhou
$5.00
Available
TWi Pharma Regains US Rights to Products from Teva
$5.00
Available
Georgia State University Out-Licenses Leukemia Drug to China's Cisen Pharma
$5.00
Available
3SBio Files for Hong Kong IPO; May Raise up to $500 Million
$5.00
Available
Fosun Pharma Rumored to Offer $480 Million for Lumenis of Israel
$5.00
Available
Crown Bioscience Buys PDX Unit from Molecular Response
$5.00
Available
WuXi PharmaTech Borrows $165 Million for New Ventures
$5.00
Available
Rainbow Medical of Israel Raises $25 Million from China Investors
$5.00
Available
ACT Genomics of Taiwan Raises $8 Million for Cancer Genomics Tests
$5.00
Available
Crown Bioscience Expands Partnership with NRCMM
$5.00
Available
NeuroVive Raises $3 Million for Taiwan Subsidiary; Plans IPO
$5.00
Available
Qiagen's TB Test Cuts Estimate of Latent TB Incidence in China
$5.00
Available